newsfilter
← Latest News
Business Wire·

QT Imaging Advances Direct U.S. Commercial Strategy to Accelerate Adoption of its Breast Acoustic CT Scanner with Two Key Hires

QTI
  • QT Imaging Holdings, Inc. appointed Jason Dyer as Vice President Regional Sales East & Dave Reinhart as Vice President Regional Sales West to advance its direct U.S. commercial strategy for the Breast Acoustic CT™ Scanner.
  • Both executives joined the company in July 2026 & report to Chief Commercial Officer Satrajit Misra.
  • The appointments mark a strategic shift from a distributor-led sales model to an integrated commercial model to enhance gross margins & direct customer engagement.
  • QT Imaging will continue its collaborative distribution arrangement with NXC Imaging, Inc., a subsidiary of Canon Medical Systems USA, Inc.
  • The new commercial team aims to build direct relationships with breast imaging centers, IDNs, & key opinion leaders to support evidence generation & physician education.
  • Strategic priorities include advancing quantitative imaging biomarkers, evaluating therapy monitoring applications, & expanding recurring revenue through software & analytics offerings.
  • Jason Dyer brings two decades of experience in breast imaging & previously served as VP of Sales at Clarix Imaging & Faxitron.
  • Dave Reinhart brings over 35 years of experience in medical device commercialization & held senior roles at organizations including Merit Medical, Clarix Imaging, & Siemens Medical Systems.
  • QT Imaging may selectively add further commercial resources in 2027 based on initial success & market feedback.
  • The company operates under the NASDAQ ticker QTI & utilizes low-frequency sound waves for its innovative, radiation-free imaging technology.